{"news_desk": "Business", "print_page": null, "section_name": "Business Day", "subsection_name": "DealBook", "byline": {"original": "By CHAD BRAY", "person": [{"rank": 1, "role": "reported", "firstname": "Chad", "organization": "", "lastname": "BRAY"}]}, "abstract": null, "type_of_material": "News", "word_count": "394", "lead_paragraph": "Hikma said it had reduced the cash portion of the offer as Boehringer Ingelheim\u2019s generic drugs business in the U.S. had lower-than-expected sales.", "pub_date": "2016-02-11T00:00:00Z", "document_type": "article", "slideshow_credits": null, "headline": {"main": "Hikma Pharmaceuticals Cuts Offer Price for Generic Drug Maker Roxane"}, "snippet": "Hikma said it had reduced the cash portion of the offer as Boehringer Ingelheim\u2019s generic drugs business in the U.S. had lower-than-expected sales.", "multimedia": [], "web_url": "http://www.nytimes.com/2016/02/11/business/dealbook/hikma-pharmaceuticals-cuts-offer-price-for-generic-drug-maker-roxane.html", "keywords": [{"rank": "1", "is_major": "N", "value": "Mergers, Acquisitions and Divestitures", "name": "subject"}, {"rank": "2", "is_major": "N", "value": "Drugs (Pharmaceuticals)", "name": "subject"}, {"rank": "3", "is_major": "N", "value": "Boehringer Ingelheim GmbH", "name": "organizations"}, {"rank": "4", "is_major": "N", "value": "Hikma Pharmaceuticals PLC", "name": "organizations"}, {"rank": "5", "is_major": "N", "value": "Amman (Jordan)", "name": "glocations"}, {"rank": "6", "is_major": "N", "value": "Germany", "name": "glocations"}, {"rank": "7", "is_major": "N", "value": "United States", "name": "glocations"}], "blog": [], "_id": "56bb077238f0d831a8916982", "source": "The New York Times"}